Aljosja Rogiers

3.0k total citations
17 papers, 367 citations indexed

About

Aljosja Rogiers is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Aljosja Rogiers has authored 17 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Aljosja Rogiers's work include Melanoma and MAPK Pathways (6 papers), CAR-T cell therapy research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Aljosja Rogiers is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), CAR-T cell therapy research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Aljosja Rogiers collaborates with scholars based in Belgium, United States and United Kingdom. Aljosja Rogiers's co-authors include Pascal Wolter, Jean‐Christophe Marine, Florian Rambow, Oliver Bechter, Patrick Schöffski, Brigitte Decallonne, Katya Op de beeck, Kathleen Van den Eynde, Etienne Waelkens and Joost J. van den Oord and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Aljosja Rogiers

14 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aljosja Rogiers Belgium 9 186 117 100 85 63 17 367
Shuijie Li China 13 248 1.3× 96 0.8× 139 1.4× 40 0.5× 57 0.9× 31 466
Junming Xu China 12 239 1.3× 97 0.8× 140 1.4× 74 0.9× 12 0.2× 27 402
Yinying Wu China 14 251 1.3× 244 2.1× 161 1.6× 90 1.1× 30 0.5× 46 538
Marco Pieraccioli Italy 15 407 2.2× 94 0.8× 172 1.7× 48 0.6× 51 0.8× 20 539
Labile Togba Soumaoro Japan 6 140 0.8× 134 1.1× 101 1.0× 42 0.5× 20 0.3× 7 405
Jennifer R. Bethard United States 12 262 1.4× 60 0.5× 87 0.9× 57 0.7× 14 0.2× 24 467
Ivana Galetić Switzerland 7 315 1.7× 64 0.5× 48 0.5× 107 1.3× 40 0.6× 10 494

Countries citing papers authored by Aljosja Rogiers

Since Specialization
Citations

This map shows the geographic impact of Aljosja Rogiers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aljosja Rogiers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aljosja Rogiers more than expected).

Fields of papers citing papers by Aljosja Rogiers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aljosja Rogiers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aljosja Rogiers. The network helps show where Aljosja Rogiers may publish in the future.

Co-authorship network of co-authors of Aljosja Rogiers

This figure shows the co-authorship network connecting the top 25 collaborators of Aljosja Rogiers. A scholar is included among the top collaborators of Aljosja Rogiers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aljosja Rogiers. Aljosja Rogiers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Theunis, Koen, Sebastiaan Vanuytven, Florian Rambow, et al.. (2025). Single-cell genome and transcriptome sequencing without upfront whole-genome amplification reveals cell state plasticity of melanoma subclones. Nucleic Acids Research. 53(6). 1 indexed citations
2.
3.
4.
5.
Rogiers, Aljosja, Florentia Dimitriou, Irene Lobón, et al.. (2023). Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy. European Journal of Cancer. 198. 113506–113506. 3 indexed citations
6.
Rogiers, Aljosja, Irene Lobón, Lavinia Spain, & Samra Turajlic. (2022). The Genetic Evolution of Metastasis. Cancer Research. 82(10). 1849–1857. 12 indexed citations
7.
Rogiers, Aljosja, et al.. (2022). Durable Responses to Chemotherapy in Patients with Metastatic Soft-Tissue Sarcoma. Oncology Research and Treatment. 45(10). 618–621.
8.
Rogiers, Aljosja, Irene Lobón, Lavinia Spain, & Samra Turajlic. (2022). The Genetic Evolution of Metastasis.. PubMed. 82(10). 1849–1857. 8 indexed citations
9.
Corre, Sébastien, Nicolas Mouchet, Héloïse M. Leclair, et al.. (2018). Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Nature Communications. 9(1). 4775–4775. 81 indexed citations
10.
Talebi, Ali, Jonas Dehairs, Florian Rambow, et al.. (2018). Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nature Communications. 9(1). 2500–2500. 105 indexed citations
11.
Higham, Christine S., Eva Dombi, Aljosja Rogiers, et al.. (2018). The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors. Neuro-Oncology. 20(6). 818–825. 65 indexed citations
12.
Rogiers, Aljosja, Pascal Wolter, & Oliver Bechter. (2017). Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination. Melanoma Research. 27(2). 164–167. 12 indexed citations
13.
Rogiers, Aljosja, Sara Vander Borght, Krizia Tuand, et al.. (2017). Response to targeted therapy in two patients with metastatic melanoma carrying rare BRAF exon 15 mutations: A598_T599insV and V600_K601delinsE. Melanoma Research. 27(5). 507–510. 7 indexed citations
14.
Rogiers, Aljosja, et al.. (2017). Molecular genetic and immunotherapeutic targets in metastatic melanoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(2). 281–293. 15 indexed citations
15.
Rogiers, Aljosja, Joost J. van den Oord, Marjan Garmyn, et al.. (2015). Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients. Drugs & Aging. 32(10). 821–834. 12 indexed citations
16.
17.
Schöffski, Patrick, et al.. (2008). Trabectedin (Yondelis ; ET-743) : a drug of marine origin for soft-tissue sarcomas. 19–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuijie Li Breakdown of academic impact, for papers by Junming Xu Breakdown of academic impact, for papers by Yinying Wu Breakdown of academic impact, for papers by Marco Pieraccioli Breakdown of academic impact, for papers by Labile Togba Soumaoro Breakdown of academic impact, for papers by Jennifer R. Bethard Breakdown of academic impact, for papers by Ivana Galetić
Rankless by CCL
2026